Description: PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
Home Page: www.merckgroup.com/id-id
Jl. TB Simatupang No. 8
Jakarta Timur,
13760
Indonesia
Phone:
62 21 2856 5600
Officers
Name | Title |
---|---|
Ms. Evie Yulin | Pres Director |
Mr. Bambang Nurcahyo | Fin. Director & Director |
Eduan Tjong | Supply Chain & Operation Mang. |
Eza Evariza | Accounting Mang. |
Miranda Andamsari | Compliance Officer |
Rinita Daniati | Head of Legal |
Ms. Melisa Sandrianti | Corp. Sec. & Corp. Communications Mang. |
Aquira Kurniawati Moeladi | Human Resource Head |
Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat | Plant Director & Independent Director |
Ms. Pachita Ramadhani | Head of Internal Audit Unit & Sr Fin. Mang. |
Exchange: JK
Country: ID
Currency: Indonesian Rupiah (Rp)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 13.1233 |
Price-to-Book MRQ: | 2.9054 |
Price-to-Sales TTM: | 1.831 |
IPO Date: | 1981-07-23 |
Fiscal Year End: | December |
Full Time Employees: | 393 |